Clinical Trial: Study of IBI333 in Subjects With Neovascular Age-related Macular Degeneration
Study Status: Completed
Recruit Status: RECRUITING
Condition: Neovascular Age-related Macular Degeneration
Study Type: INTERVENTIONAL
Official Title: A Dose Escalation Phase I Clinical Study to Evaluate the Tolerability and Safety of IBI333 in Subjects With Neovascular Age-related Macular Degeneration (nAMD)
Brief Summary:
This study is designed for multi-center, open-label, dose escalation phase I trial to evaluate the safety and tolerability of a single and multiple intravitreal injection of IBI333 in subjects with neovascular age-related macular degeneration (nAMD).
Read more